| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438312A1 Anthrone derivatives and their use as jnk inhibitors |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | CA2437161A1 Anti-interferon-.alpha. antibodies |
| 08/29/2002 | CA2435177A1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 08/29/2002 | CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/28/2002 | EP1234581A1 Wound contraction inhibitors |
| 08/28/2002 | EP1234574A1 Hair growth stimulant |
| 08/28/2002 | EP1234571A1 Topical composition containing a hydroxystilbene and a polyol |
| 08/28/2002 | EP1234185A2 Pin1 as a marker for abnormal cell growth |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233930A1 A particle comprising a host lattice and a guest, its preparation and use in ultraviolet light screening compositions |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233772A1 Boron compounds and complexes as anti-inflammatory agents |
| 08/28/2002 | EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1233748A1 Retinaldehyde combination with antifungal activity |
| 08/28/2002 | EP1233738A1 Use of nonimmunosuppressive cyclosporin derivatives for hair growth |
| 08/28/2002 | EP1123092B1 Fumaric acid microtablets |
| 08/28/2002 | EP1082114B1 Hydroxyomeprazole compositions and uses |
| 08/28/2002 | EP0973524B1 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 08/28/2002 | EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 08/28/2002 | CN1366461A Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1366460A Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1366459A Preventive or therapeutic drugs for various eosinophilia-realated diseases containing chymase inhibitors as active ingredient |
| 08/28/2002 | CN1366458A Hair growth and hair formation controlling agents |
| 08/28/2002 | CN1365830A Capsule 'Linkangning' |
| 08/28/2002 | CN1365817A Chinese medicine (instant particles) for treating intractable tinea and its preparing process |
| 08/28/2002 | CN1365800A Nano medicine for treating skin itching and its preparing process |
| 08/28/2002 | CN1365762A Nano heroubill medicine and its preparing process |
| 08/28/2002 | CN1365743A Nano medicine 'Keyin' and its preparing process |
| 08/28/2002 | CN1365735A Nano medicine for treating burn and its preparing process |
| 08/28/2002 | CN1365732A Nano medicine for growing muscle and its preparing process |
| 08/28/2002 | CN1365689A Nano medicine 'Jiuyisan' and its preparing process |
| 08/28/2002 | CN1365664A Medicine for removing vegetation from human body and its preparing process and application |
| 08/28/2002 | CN1365662A Method of reducing appearance of black colour at lower part of eye |
| 08/28/2002 | CN1365661A Plaster for treating alopesia |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/28/2002 | CN1089759C Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 08/28/2002 | CN1089605C Capsule for treatment of leukoderma |
| 08/28/2002 | CN1089597C Psoriasis treating Chinese medicine preparation and its preparing process |
| 08/28/2002 | CN1089594C Traditional Chinese medicine for curing psoriasis |
| 08/28/2002 | CN1089587C Stable cross-linked compound of polyvinyl pyrrolidone and iodine and method for preparation of said compound |
| 08/28/2002 | CN1089583C Mycophenolate mofetil high dose oral suspensions |
| 08/28/2002 | CN1089578C Cosmetic containing microecological regulator |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441012 Chemical compounds |
| 08/27/2002 | US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6441000 Compounds useful in therapy |
| 08/27/2002 | US6440978 A therapeutical agent for dermatitis comprises 7-amino-3-(halo substituted or unsubstitued benzyl)-1,2,3-tetrahydro-1-phenylpyrido(2,3-d)pyrimidin-2,4-dione |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/27/2002 | US6440938 Prevention and/or treatment of allergic conditions |
| 08/27/2002 | US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents |
| 08/27/2002 | US6440679 Dermatomyositis-specific auto-antigen |
| 08/27/2002 | US6440465 Topical composition for the treatment of psoriasis and related skin disorders |
| 08/27/2002 | US6440435 Use of N-acylamino acid compounds as texturing agents |
| 08/27/2002 | US6440428 Podophyllotoxin preparation containing triglycerides |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | CA2335440C Chinese herbs extract |
| 08/27/2002 | CA2033392C A-nor-steroid-3-carboxylic acid derivatives |
| 08/27/2002 | CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase |
| 08/27/2002 | CA2015838C Method of topically treating acne vulgaris |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064603A1 Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 08/22/2002 | WO2002064595A1 Triazolo compounds as mmp inhibitors |
| 08/22/2002 | WO2002064594A2 6-substituted pyrido-pyrimidines |
| 08/22/2002 | WO2002064589A1 Laulimalide derivatives |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064580A1 Lactone compounds as novel photoinitiators |
| 08/22/2002 | WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES |
| 08/22/2002 | WO2002064178A1 Use of green tea extract for wound healing |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064151A1 Acrochordon alleviation |
| 08/22/2002 | WO2002064150A1 Whitening compositions containing ascomycete derived enzyme |
| 08/22/2002 | WO2002064149A1 Method for the prevention of tissue elastic fiber injury |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064110A2 Carotenoid-loaded liposomes |